New study sheds light on CMV treatment in kidney transplant patients
NCT ID NCT06568055
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study reviewed medical records from a UK registry to understand how cytomegalovirus (CMV) infection is managed in adults after a kidney transplant. Researchers looked at data from 330 patients over 7 years to see how common refractory CMV is, what treatments are used, and how well they work. The goal is to improve future care for transplant recipients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
RaDaR (part of the UK Kidney Association)
Bristol, Southwestern England, United Kingdom
Conditions
Explore the condition pages connected to this study.